{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T08:03:05Z","timestamp":1783065785351,"version":"3.54.6"},"reference-count":56,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Department of Epidemiology and Population Health, and the Department of Urology, at Albert Einstein College of Medicine and Montefiore Medical Center"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Androgenetic alopecia, also known as male pattern baldness (MPB), is a common hair loss disorder among middle-aged men. MPB shares similar risk factors with prostate cancer (PrCa), including advancing age, family history, and sex hormones. Several studies have examined the associations between MPB and PrCa; however, the evidence remains unclear. We carried out an updated meta-analysis of epidemiological studies that examined the relationship between age at onset and patterns of MPB (either frontal, vertex, or both) and their associations with risks of total and aggressive PrCa. Methods: A literature search was performed using PubMed and Web of Science databases for epidemiological studies published between 1 January 2000 and 31 December 2024 that examined the associations between MPB and PrCa. From each eligible study, relevant data were extracted on study design and population, sample size, prevalence of MPB at various ages, and their association with PrCa. Pooled relative risks (RR) and corresponding 95% confidence intervals (CI) were calculated using the Der-Simonian and Laird random-effects models. Heterogeneity across studies was assessed by I2 statistics, while the quality of studies was evaluated using the Newcastle\u2013Ottawa Scale. Results: A total of 19 observational studies, including 17,810 cases and 146,806 controls\/non-cases, were analyzed. The prevalence of MPB increased from 5% to 65% with aging and varied across the studies. Both frontal and vertex MPB were associated with a pooled RR of 1.08 (95% CI 1.02\u20131.14) for total PrCa, but there was no association with frontal-only MPB. Younger-onset MPB (&lt;40 years old) was also associated with an RR = 1.13 (95% CI 0.96\u20131.31) for PrCa, although results were not statistically significant. Vertex-only MPB was associated with more aggressive PrCa (pooled RR = 1.14; 95% CI 1.02\u20131.25); however, there was substantial heterogeneity in the definition of aggressive PrCa across the studies. Conclusions: Men with both frontal and vertex MPB have a modestly elevated risk of PrCa. However, most studies were conducted in Caucasian men and they did not evaluate effect modifications by genetic variations in androgen metabolism pathway genes or changes in serum levels of androgens with aging. Large prospective cohort studies with more accurate longitudinal assessment of hair loss patterns are needed to better understand the complex relationship between genetic susceptibility, endogenous hormones, MPB, and subsequent risk of PrCa.<\/jats:p>","DOI":"10.3390\/cancers17213581","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:02:03Z","timestamp":1762419723000},"page":"3581","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Androgenetic Alopecia and Risks of Overall and Aggressive Prostate Cancer: An Updated Systematic Review and Meta-Analysis"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9395-6375","authenticated-orcid":false,"given":"David G.","family":"Hanelin","sequence":"first","affiliation":[{"name":"Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sapir","family":"Amar","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA"},{"name":"Yeshiva University, New York, NY  10033, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6248-5790","authenticated-orcid":false,"given":"Ilir","family":"Agalliu","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA"},{"name":"Department of Urology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10461, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"ref_1","unstructured":"American Cancer Society (ACS) (2024). Cancer Facts and Figures 2024, American Cancer Society."},{"key":"ref_2","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0140-6736(14)61947-4","article-title":"Prostate cancer","volume":"387","author":"Attard","year":"2016","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1002\/cncr.11262","article-title":"Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: A meta-analysis","volume":"97","author":"Zeegers","year":"2003","journal-title":"Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/oxfordjournals.epirev.a000795","article-title":"Hormones and Prostate Cancer: What\u2019s Next?","volume":"23","author":"Hsing","year":"2001","journal-title":"Epidemiol. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jsbmb.2004.10.002","article-title":"The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer","volume":"92","author":"Platz","year":"2004","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/jnci\/djm323","article-title":"Endogenous sex hormones and prostate cancer: A collaborative analysis of 18 prospective studies","volume":"100","author":"Roddam","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/bju.13417","article-title":"Endogenous and exogenous testosterone and the risk of prostate cancer and increased prostate-specific antigen (PSA) level: A meta-analysis","volume":"118","author":"Boyle","year":"2016","journal-title":"BJU Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399402005112","article-title":"Androgenetic alopecia: Pathogenesis and potential for therapy","volume":"4","author":"Ellis","year":"2002","journal-title":"Expert Rev. Mol. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/00007611-197511000-00009","article-title":"Male pattern baldness: Classification and incidence","volume":"68","author":"Norwood","year":"1975","journal-title":"South. Med. J."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Cuevas-Diaz Duran, R., Martinez-Ledesma, E., Garcia-Garcia, M., Bajo Gauzin, D., Sarro-Ramirez, A., Gonzalez-Carrillo, C., Rodriguez-Sardin, D., Fuentes, A., and Cardenas-Lopez, A. (2024). The Biology and Genomics of Human Hair Follicles: A Focus on Androgenetic Alopecia. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25052542"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0303-7207(02)00372-6","article-title":"Androgens and alopecia","volume":"198","author":"Kaufman","year":"2002","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1365-2230.2011.04186.x","article-title":"Androgen receptor gene polymorphisms and risk for androgenetic alopecia: A meta-analysis","volume":"37","author":"Zhuo","year":"2012","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Liu, L.P., Wariboko, M.A., Hu, X., Wang, Z.H., Wu, Q., and Li, Y.M. (2024). Factors associated with early-onset androgenetic alopecia: A scoping review. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0299212"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jaad.2012.11.034","article-title":"Androgenetic alopecia and risk of prostate cancer: A systematic review and meta-analysis","volume":"68","author":"Amoretti","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e11379","DOI":"10.1097\/MD.0000000000011379","article-title":"Male pattern baldness and incidence of prostate cancer: A systematic review and meta-analysis","volume":"97","author":"He","year":"2018","journal-title":"Medicine"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_18","unstructured":"Wells, G.A., Shea, B., O\u2019Connell, D., Peterson, J., Welch, V., Losos, M., and Tugwell, P. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. Available online: https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/ije\/dym018","article-title":"Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: A systematic review and annotated bibliography","volume":"36","author":"Sanderson","year":"2007","journal-title":"Int. J. Epidemiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1136\/bmj.315.7121.1533","article-title":"Meta-analysis: Principles and procedures","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"ref_23","first-page":"523","article-title":"Male pattern baldness and clinical prostate cancer in the epidemiologic follow-up of the first National Health and Nutrition Examination Survey","volume":"9","author":"Hawk","year":"2000","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_24","first-page":"325","article-title":"Early onset baldness and prostate cancer risk","volume":"9","author":"Schildkraut","year":"2000","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_25","first-page":"549","article-title":"Androgenetic alopecia and prostate cancer: Findings from an Australian case-control study","volume":"11","author":"Giles","year":"2002","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/13685530802400995","article-title":"Baldness, benign prostate hyperplasia, prostate cancer and androgen levels","volume":"11","author":"Faydaci","year":"2008","journal-title":"Aging Male"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.canep.2010.02.003","article-title":"Male pattern baldness and prostate cancer risk in a population-based case-control study","volume":"34","author":"Wright","year":"2010","journal-title":"Cancer Epidemiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1016\/j.ejca.2010.05.020","article-title":"Androgenic alopecia is not useful as an indicator of men at high risk of prostate cancer","volume":"46","author":"Cremers","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1093\/annonc\/mdq695","article-title":"Male pattern baldness and the risk of prostate cancer","volume":"22","author":"Yassa","year":"2011","journal-title":"Ann. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1158\/1055-9965.EPI-12-0860","article-title":"Age-dependent associations between androgenetic alopecia and prostate cancer risk","volume":"22","author":"Muller","year":"2013","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_31","first-page":"1045","article-title":"Androgenetic alopecia at various ages and prostate cancer risk in an equal-access multiethnic case-control series of veterans","volume":"24","author":"Thomas","year":"2013","journal-title":"Cancer Causes Control"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1158\/1055-9965.EPI-12-0944","article-title":"Relationship of early-onset baldness to prostate cancer in African-American men","volume":"22","author":"Morales","year":"2013","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/jdv.12468","article-title":"Androgenetic alopecia and polymorphism of the androgen receptor gene (SNP rs6152) in patients with benign prostate hyperplasia or prostate cancer","volume":"29","author":"Kucerova","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/pros.22927","article-title":"Male pattern baldness in relation to prostate cancer risks: An analysis in the VITamins and lifestyle (VITAL) cohort study","volume":"75","author":"Zhou","year":"2015","journal-title":"Prostate"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1200\/JCO.2014.55.4279","article-title":"Relationship between male pattern baldness and the risk of aggressive prostate cancer: An analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial","volume":"33","author":"Zhou","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"E424","DOI":"10.5489\/cuaj.3813","article-title":"The association of male pattern baldness and risk of cancer and high-grade disease among men presenting for prostate biopsy","volume":"10","author":"Bhindi","year":"2016","journal-title":"Can. Urol. Assoc. J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/21681805.2016.1145734","article-title":"Postscreening follow-up of the Finnish Prostate Cancer Screening Trial on putative prostate cancer risk factors: Vitamin and mineral use, male pattern baldness, pubertal development and non-steroidal anti-inflammatory drug use","volume":"50","author":"Sarre","year":"2016","journal-title":"Scand. J. Urol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/aje\/kwv190","article-title":"Male Pattern Baldness in Relation to Prostate Cancer-Specific Mortality: A Prospective Analysis in the NHANES I Epidemiologic Follow-up Study","volume":"183","author":"Zhou","year":"2016","journal-title":"Am. J. Epidemiol."},{"key":"ref_39","first-page":"93","article-title":"Early-onset baldness and the risk of aggressive prostate cancer: Findings from a case-control study","volume":"29","author":"Papa","year":"2018","journal-title":"Cancer Causes Control"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1158\/1055-9965.EPI-19-1236","article-title":"Baldness and Risk of Prostate Cancer in the Health Professionals Follow-up Study","volume":"29","author":"Khan","year":"2020","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1158\/1055-9965.EPI-23-0908","article-title":"Male-Pattern Vertex Baldness Trajectories, Chest Hair Patterns, and Odds of Overall and Aggressive Prostate Cancer","volume":"33","author":"Salmon","year":"2024","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/exd.14130","article-title":"Hormonal regulation in male androgenetic alopecia-Sex hormones and beyond: Evidence from recent genetic studies","volume":"29","author":"Hochfeld","year":"2020","journal-title":"Exp. Dermatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0303-7207(02)00368-4","article-title":"Androgens and male physiology the syndrome of 5alpha-reductase-2 deficiency","volume":"198","author":"Zhu","year":"2002","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mce.2017.08.016","article-title":"Intracrine androgen biosynthesis, metabolism and action revisited","volume":"465","author":"Schiffer","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000019909","article-title":"Androgen metabolism and prostate cancer: Establishing a model of genetic susceptibility","volume":"35","author":"Ross","year":"2012","journal-title":"Eur. Urol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdermsci.2010.10.015","article-title":"Molecular basis of androgenetic alopecia: From androgen to paracrine mediators through dermal papilla","volume":"61","author":"Inui","year":"2011","journal-title":"J. Dermatol. Sci."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Weng, H., Li, S., Huang, J.Y., He, Z.Q., Meng, X.Y., Cao, Y., Fang, C., and Zeng, X.T. (2017). Androgen receptor gene polymorphisms and risk of prostate cancer: A meta-analysis. Sci. Rep., 7.","DOI":"10.1038\/srep40554"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1046\/j.1523-1747.2001.01261.x","article-title":"Polymorphism of the androgen receptor gene is associated with male pattern baldness","volume":"116","author":"Ellis","year":"2001","journal-title":"J. Investig. Dermatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/aje\/kwp318","article-title":"Steroid 5-alpha-reductase Type 2 (SRD5a2) gene polymorphisms and risk of prostate cancer: A HuGE review","volume":"171","author":"Li","year":"2010","journal-title":"Am. J. Epidemiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1158\/1078-0432.CCR-13-1100","article-title":"Importance of 5alpha-reductase gene polymorphisms on circulating and intraprostatic androgens in prostate cancer","volume":"20","author":"Levesque","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/iju.15424","article-title":"Exploring androgen receptor signaling pathway in prostate cancer: A path to new discoveries","volume":"31","author":"Obinata","year":"2024","journal-title":"Int. J. Urol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/s41467-017-01490-8","article-title":"GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk","volume":"8","author":"Pirastu","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"14694","DOI":"10.1038\/ncomms14694","article-title":"Meta-analysis identifies novel risk loci and yields systematic insights into the biology of male-pattern baldness","volume":"8","author":"Herold","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"100428","DOI":"10.1016\/j.xhgg.2025.100428","article-title":"Uncovering the genetic architecture and evolutionary roots of androgenetic alopecia in African men","volume":"6","author":"Janivara","year":"2025","journal-title":"Hum. Genet. Genom. Adv."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jamadermatol.2023.0016","article-title":"Overall and Racial and Ethnic Subgroup Prevalences of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis","volume":"159","author":"Sy","year":"2023","journal-title":"JAMA Dermatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"243","DOI":"10.5021\/ad.2012.24.3.243","article-title":"Characteristics of androgenetic alopecia in asian","volume":"24","author":"Lee","year":"2012","journal-title":"Ann. Dermatol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/21\/3581\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:16:33Z","timestamp":1762420593000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/21\/3581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":56,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["cancers17213581"],"URL":"https:\/\/doi.org\/10.3390\/cancers17213581","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]}}}